2C-B: Difference between revisions

>Blackhole
added drugbank link
>Utaninja
m Added source
Line 26: Line 26:
Shortly after gaining traction in the underground psychotherapy community, 2C-B became popular in the recreational drug scene. It was well-liked as a [[MDMA]] substitute in raves and club parties due to its minimal comedown and a clear, euphoric headspace.  
Shortly after gaining traction in the underground psychotherapy community, 2C-B became popular in the recreational drug scene. It was well-liked as a [[MDMA]] substitute in raves and club parties due to its minimal comedown and a clear, euphoric headspace.  


In the 1980s and early 1990s, several foreign companies legally manufactured the substance under the brand names "Nexus", "Erox", and "Performax" and advertised that it would alleviate impotence, frigidity, and diminished libido. It was sold at adult book and video stores, "head" shops, and some nightclubs. The DEA reported its distribution in Miami, Florida in the form of yellow pills marketed as an aphrodisiac.{{citation needed}}
In the 1980s and early 1990s, several foreign companies legally manufactured the substance under the brand names "Nexus", "Erox", and "Performax" and advertised that it would alleviate impotence, frigidity, and diminished libido. It was sold at adult book and video stores, "head" shops, and some nightclubs. The DEA reported its distribution in Miami, Florida in the form of yellow pills marketed as an aphrodisiac.<ref>https://www.justice.gov/archive/ndic/pubs0/665/665p.pdf</ref>


In the United States, it gained popularity as an alternative to MDMA after the latter was classified as a Schedule I substance in 1985. The increasing popularity of 2C-B led to it also being placed in Schedule I in 1995.<ref name="DEA2001" /> It saw a resurgence in interest in the 2000s, with the advent of the [[research chemicals|"research chemicals"]]/"designer drugs" scene and darknet markets.  
In the United States, it gained popularity as an alternative to MDMA after the latter was classified as a Schedule I substance in 1985. The increasing popularity of 2C-B led to it also being placed in Schedule I in 1995.<ref name="DEA2001" /> It saw a resurgence in interest in the 2000s, with the advent of the [[research chemicals|"research chemicals"]]/"designer drugs" scene and darknet markets.  
Retrieved from "http://psy.st/wiki/2C-B"